Agroz Inc. Announces Receipt of NASDAQ Staff Determination and Implementation of Compliance Plan

Agroz faces imminent Nasdaq delisting after sustained rule breaches and missing its annual report.

What the company is saying

Agroz Inc. discloses receipt of a Nasdaq Staff Determination Letter dated August 18, 2026, confirming a decision to delist its securities due to non-compliance with listing rules. The company highlights two main compliance failures: its share price remained below US$1.00 for 30 consecutive business days, and it has not filed its annual report on Form 20-F for the year ended December 31, 2025. Management asserts that these regulatory issues do not affect daily operations, customers, or employees, but provides no supporting data. The narrative emphasizes a plan to appeal the delisting by requesting a hearing before the August 25, 2026 deadline, and outlines steps to regain compliance, including a proposed 1-for-10 reverse share split and the expedited completion of the overdue annual report. Agroz notes the appointment of Golden Eagle CPAs LLC, a PCAOB-registered U.S. accounting firm, to accelerate the audit process. The tone is procedural and focused on regulatory process, with unsupported promotional language about the company’s innovation and vertical integration.

What the data suggests

The only hard data disclosed are compliance failures: the share price stayed below US$1.00 for 30 consecutive business days, and the annual report for 2025 remains unfiled. No revenue, profit, cash flow, or operational metrics are provided. The company’s financial trajectory is impossible to assess due to the absence of any substantive financial disclosure. The proposed 1-for-10 reverse split is a standard response to a low share price but does not address underlying business performance. The appointment of a new auditor and the stated target to file the annual report by mid-October 2026 are procedural steps, not evidence of financial health. The claim that operations are unaffected by the delisting notice is not supported by any operational or customer data. Overall, the data quality is poor, transparency is minimal, and there is no evidence to support claims of business strength or innovation.

Analysis

The announcement is a factual regulatory update regarding Agroz Inc.'s receipt of a Nasdaq Staff Determination Letter and outlines the company's intended compliance actions, such as requesting a hearing, implementing a reverse share split, and expediting the filing of its overdue annual report. The language is procedural and does not overstate progress or prospects; most forward-looking statements are limited to the company's intent to comply with listing requirements and the expected timeline for filing. There are no exaggerated claims of operational or financial improvement, and no large capital outlay is disclosed. The only unsupported claims are generic statements about the company's innovation and the assertion that the Staff Determination does not affect operations, neither of which are material to the investment case in this context. No profitability, revenue, or operational metrics are disclosed, and the announcement does not attempt to frame the situation positively or negatively. The gap between narrative and evidence is minimal.

Risk flags

• ●Regulatory risk is acute: Nasdaq has already issued a formal determination to delist Agroz Inc. due to two separate rule breaches—sustained sub-US$1.00 share price and failure to file the annual report. Delisting would severely restrict liquidity and may trigger further negative consequences for shareholders.
• ●Disclosure risk is material: The company has not filed its annual report for the fiscal year ended December 31, 2025, and provides no current financial or operational data in this announcement. This lack of transparency prevents investors from assessing the company’s financial health or business trajectory.
• ●Execution risk is elevated: The company must complete a 1-for-10 reverse share split and finalize its overdue annual report audit within a tight timeframe. Both actions are necessary but not sufficient for regaining compliance, and delays or audit complications could result in permanent delisting.
• ●Operational risk is understated: The claim that the Staff Determination does not affect operations, customers, or employees is unsupported by any data. Regulatory crises often distract management and can disrupt business relationships, even if not immediately visible.

Bottom line

Agroz Inc. is on the verge of being delisted from Nasdaq after failing to maintain a US$1.00 share price for 30 consecutive business days and missing its 2025 annual report filing. The company’s plan to appeal, implement a 1-for-10 reverse split, and expedite its audit are standard procedural responses but do not guarantee continued listing or address any underlying business issues. No financial, operational, or customer data is disclosed, leaving investors unable to assess the company’s viability or prospects. The narrative’s assurances about unaffected operations are unsupported. Unless Agroz rapidly files its overdue annual report and successfully executes the reverse split, the risk of delisting and loss of market access is high. The most important takeaway is that this is a regulatory crisis with no evidence of underlying business strength or recovery.

Announcement summary

(NASDAQ:AGRZ) Agroz Inc. announced that it received a Staff Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC dated August 18, 2026, stating that Nasdaq has determined to delist the Company's securities from the Nasdaq Capital Market due to non-compliance with certain listing rules. The closing bid price of the Company's ordinary shares remained below US$1.00 per share for 30 consecutive business days, resulting in non-compliance with Nasdaq Listing Rule 5550(a)(2). The Company has not yet filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, resulting in non-compliance with Nasdaq Listing Rule 5250(c)(1). The Company intends to submit a timely request for a hearing before the Nasdaq Hearings Panel by the August 25, 2026 deadline to appeal the Staff Determination. The Company is finalizing the submission of the necessary corporate-action application to implement a 1-for-10 reverse share split of its ordinary shares. The Company has appointed Golden Eagle CPAs LLC, a United States-based public accounting firm registered with the Public Company Accounting Oversight Board, to expedite the audit process required for completion of the Company's Form 20-F for the fiscal year ended December 31, 2025. The Company is currently targeting completion of the outstanding Form 20-F by mid-October 2026.

Disagree with this article?